Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Opsens Inc T.OPS

Healthcare Medical Devices
OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR... see more

Recent & Breaking News (TSX:OPS)

OpSens to Host Fourth Quarter Fiscal Year 2021 Financial Results Conference Call and Year-End Update on Tuesday, November 23, 2021

PR Newswire November 17, 2021

OpSens will Participate at Stifel 2021 Virtual Healthcare Conference and Canaccord Genuity MedTech & Diagnostics Forum

PR Newswire November 10, 2021

OPSENS' SAVVYWIRE(TM) Featured at the Transcatheter Cardiovascular Therapeutics 2021 Annual Meeting in Orlando

PR Newswire November 8, 2021

OpSens Successfully Treats First Patients in Human Clinical Study for TAVR Procedure

PR Newswire October 13, 2021

OpSens to Present at the Lytham Partners Fall 2021 Investor Conference

PR Newswire September 29, 2021

OPSENS Receives Approval from Health Canada to Initiate First In-Man Clinical Study for its New Guidewire for the TAVR Procedure

PR Newswire September 20, 2021

OpSens Appoints Lori Chmura to its Board of Directors

PR Newswire September 8, 2021

OpSens Announces Third Quarter Fiscal 2021 Record Financial Results

PR Newswire July 13, 2021

OpSens to Host Third Quarter Fiscal Year 2021 Financial Results Conference Call on Tuesday, July 13, 2021

PR Newswire July 7, 2021

OpSens Solutions Receives Funding Support to Jointly Develop an Optical-Based Fuel Monitoring System for Aerospace Applications, Including Civil Aircrafts

Canada NewsWire June 16, 2021

OpSens will Participate and Present at two Investment Conferences - Lytham Partners and Raymond James

Canada NewsWire June 9, 2021

OpSens to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference

Canada NewsWire May 13, 2021

OpSens Integrates its OptoWire's dPR and FFR Algorithms Within Cathmedical Cardiovascular's Picasso System in Spain

Canada NewsWire April 21, 2021

OpSens Announces Second Quarter Fiscal 2021 Financial Results and Record FFR and dPR Revenues

Canada NewsWire April 14, 2021

OpSens Awarded Innovative Technology Contract by Vizient for OptoWire III

Canada NewsWire April 7, 2021

OpSens to Host Second Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, April 14, 2021

Canada NewsWire April 6, 2021

OpSens to Present at Lytham Partners Spring 2021 Investor Conference

Canada NewsWire March 22, 2021

OpSens Announces Closing of $28.75 Million Bought Deal Public Offering Including $3.75 Million Over-Allotment Option Exercised in Full

Canada NewsWire February 25, 2021

OpSens Obtains CE Marking for the OptoWire III

Canada NewsWire February 18, 2021

OpSens Solutions Fiber Optic Sensing Technology Selected for the International Thermonuclear Experimental Reactor (ITER)

Canada NewsWire February 8, 2021